Related references
Note: Only part of the references are listed.Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia
Olga Goronkova et al.
BLOOD ADVANCES (2023)
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
R. Peffault de Latour et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag
Yoshitaka Zaimoku et al.
HAEMATOLOGICA (2022)
Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges
Zheng-Li Xu et al.
BONE MARROW TRANSPLANTATION (2021)
Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia
Emma M. Groarke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Effects of Eltrombopag on In Vitro Macrophage Polarization in Pediatric Immune Thrombocytopenia
Alessandra Di Paola et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Eltrombopag in children with severe aplastic anemia
Harry Lesmana et al.
PEDIATRIC BLOOD & CANCER (2021)
Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children
Ma Jie et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2021)
Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study
Meixin Fang et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2021)
Role of eltrombopag in severe aplastic anemia treatment in children
Min-Yu Su et al.
PEDIATRICS AND NEONATOLOGY (2021)
Current evidence and the emerging role of eltrombopag in severe aplastic anemia
Beatrice Drexler et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2021)
Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia
Maria Filippidou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Low Dose of Eltrombopag with Long-Term Response in Children with Severe Aplastic Anemia, Less Morbi-Mortality Better Quality of Life
Norma C. Lopez-Santiago et al.
BLOOD (2019)
Outcomes in Pediatric Patients with Severe Aplastic Anemia Treated with Standard Immunosuppression and Eltrombopag
Emma M. Groarke et al.
BLOOD (2019)
Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis
Francesca Punzo et al.
PLOS ONE (2018)
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia
Danielle M. Townsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
Tomas Jose Gonzalez-Lopez et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
Matthew J. Olnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)